Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Learn the best actions to take with your credit card points. Make informed decisions to maximize your rewards and benefits.
25,531 articlesA biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Retirees who depend solely on dividend-focused ETFs may be trimming potential income. Experts urge adding a deliberat...
You’ve hit the IRA max. Now what? This practical guide lays out clear steps, tax-smart options, and real-world scenar...
When a company director sells millions after a sharp rally, it stirs worry. But insider activity is nuanced. This gui...
MP Materials is capturing attention as the only fully integrated u.s. rare earth producer. With buzz around potential...
Investors are weighing growth, profitability, and risk after the newest earnings release. Here’s a practical, plain-l...
MakeMyTrip faces a pivotal year as makemytrip (mmyt) 2026 earnings reveal growth amid rising costs. This analysis bre...
Lockup terms can shape the first days of a stock's life after an IPO. This guide explains standard practices, what an...
As DocuSign navigates a changing digital transaction landscape, the docusign (DOCU) 2027 earnings thesis hinges on re...
The AI IPO race is accelerating as OpenAI joins the fray after Anthropic. This article breaks down what the filing me...
A director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
Ford and GM are reshaping their business models by moving into energy-related assets like batteries, charging network...